Lillys phase 2 retatrutide trial achieved up to 17.5% mean weight reduction at 24 weeks
It contains bioactive compounds, such as lactoferrin, glutamine, and immunoglobulins, which block the activity of dipeptidyl peptidase-4, a gut enzyme that breaks down incretin hormones, including GLP-1
Can Glucagon-like Peptide-1 Receptor Agonists Cause Acute Kidney Injury
However, research-grade Retatrutide is available for laboratory and scientific study through trusted suppliers
Some of the key benefits include: Steady, Clinically Significant Weight Loss: Most patients see gradual, consistent weight reduction over time
Although Ozempic was initially approved specifically for diabetes management, it has gained attention due to its demonstrated ability to support significant weight loss in clinical studies